Single-cell approaches in human peripheral blood mononuclear cells and BALF from patients stratified by COVID-19 severity have revealed that type I, II, and III interferons are sustained at higher amounts in severe patients, whereas interferons declined in moderate patients over time from symptom onset (6, 9, 35). Here, SGCG is linked to COVID-19.